RITUXIMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where RITUXIMAB was used for Prostate cancer.
Most Reported Side Effects for RITUXIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 39,751 | 22.3% | 6,335 | 11,201 |
| Drug ineffective | 32,186 | 18.0% | 3,169 | 7,462 |
| Rheumatoid arthritis | 19,850 | 11.1% | 2,167 | 5,477 |
| Pain | 16,675 | 9.3% | 2,124 | 5,092 |
| Fatigue | 15,602 | 8.7% | 2,477 | 5,183 |
| Arthralgia | 12,529 | 7.0% | 1,864 | 4,945 |
| Rash | 12,102 | 6.8% | 2,343 | 4,411 |
| Drug intolerance | 11,876 | 6.7% | 1,703 | 3,314 |
| Infusion related reaction | 11,871 | 6.7% | 2,239 | 4,458 |
| Joint swelling | 11,170 | 6.3% | 2,145 | 4,040 |
| Pneumonia | 11,068 | 6.2% | 3,093 | 5,544 |
| Contraindicated product administered | 10,479 | 5.9% | 1,426 | 2,981 |
| Nausea | 10,250 | 5.7% | 1,642 | 4,430 |
| Alopecia | 10,119 | 5.7% | 1,721 | 3,105 |
| Pyrexia | 10,061 | 5.6% | 2,054 | 5,833 |
Other Indications for RITUXIMAB
Rheumatoid arthritis (40,017)
Product used for unknown indication (24,023)
Diffuse large b-cell lymphoma (22,275)
B-cell lymphoma (7,811)
Chronic lymphocytic leukaemia (7,231)
Non-hodgkin's lymphoma (5,959)
Mantle cell lymphoma (3,940)
Follicular lymphoma (3,294)
Granulomatosis with polyangiitis (3,222)
Lymphoma (3,142)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)